title: Late breaking trials of 2015 in structural heart disease and peripheral artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA.
abstract: With the large number of late breaking clinical trials presented at major meetings, it is often difficult to stay current with advances in interventional cardiology. Therefore, the SCAI Publications Committee summarizes and provides editorial commentary on the most important structural heart and peripheral artery disease late-breaking trials from 2015. © 2016 Wiley Periodicals, Inc.
authors.affiliation: University of Colorado and Denver VA Medical Center, Colorado.
authors.forename: Ehrin J
authors.initials: EJ
authors.lastname: Armstrong
authors.affiliation: Saint Luke's Mid America Heart Institute, Missouri.
authors.forename: Adnan K
authors.initials: AK
authors.lastname: Chhatriwalla
authors.affiliation: The Heart Hospital Baylor Plano, Texas.
authors.forename: Molly
authors.initials: M
authors.lastname: Szerlip
authors.affiliation: New York-Presbyterian Hospital, Weill Cornell Medical College, New York.
authors.forename: Rajesh V
authors.initials: RV
authors.lastname: Swaminathan
authors.affiliation: Ochsner Medical Center, Louisiana.
authors.forename: Rajan A G
authors.initials: RA
authors.lastname: Patel
mesh_terms: D002309:Cardiology / Q000379:methods*; D002986:Clinical Trials as Topic / Q000379:methods*; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D058729:Peripheral Arterial Disease / Q000628:therapy*; D012955:Societies, Medical; D014481:United States